Booklets

PCSK9 and Atherosclerosis - R3i

PCSK9 and Atherosclerosis

By Professors Jean Davignon, Jean-Charles Fruchart and Michel Hermans

Created by Professors Jean Davignon , Jean-Charles Fruchart and Michel Hermans, the downloadable deck of 242 slides discusses the potential role for anti-PCSK9 mAbs in the future management of cardiovascular disease.
 
Authors review unmet needs in the treatment of dyslipidemia, the discovery and structure of PCSK9,PCSK9 levels in health and disease, PCSK9-drug interactions focusing on statin trials, current approaches to PCSK9 inhibition, and results from anti-PCSK9 mAb pre-clinical and clinical trials.